Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170917127> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2170917127 endingPage "A407" @default.
- W2170917127 startingPage "A407" @default.
- W2170917127 abstract "Treatment continuation of four long acting, injectable, antipsychotic drugs: paliperidone palmitate, risperidone microspheres, olanzapine pamoate and haloperidol decanoate, was evaluated in the Dutch outpatient setting using panel data from public pharmacies. Restart rates, maintenance dose distribution, age distribution and frequency of co-prescriptions were also investigated. The IMS LifelinkTM Treatment Dynamics database was used, applying appropriate selection criteria. Four patient cohorts that started paliperidone palmitate, risperidone microspheres, olanzapine pamoate or haloperidol decanoate treatment, between 1 April 2011 and 31 March 2012, and 1 October 2012 and 31 September 2013 were analyzed. All cohorts included at least 13 months of follow up. Treatment continuation was investigated. After 180 days, in both study periods, a significantly higher percentage of patients continued treatment with paliperidone palmitate. After six months, respectively 59% and 55% of patients continued paliperidone palmitate. For risperidone microspheres this was 42% and 40%, for olanzapine pamoate 25% and 43%, and for haloperidol decanoate 42% and 47%. In both study periods, significantly higher percentages of patients restarted index treatment within 3 months when using paliperidone palmitate (42% and 40%) or olanzapine pamoate (44% and 42%) compared to risperidone microspheres (35% and 33%) or haloperidol decanoate (26% and 28%). For all therapies, dosing was comparable between treatment initiation and discontinuation. Medication used to treat extrapyramidal symptoms was on average more frequently used with haloperidol decanoate (24% and 18%) than with paliperidone palmitate (4% and 5%) risperidone microspheres (11% and 3%), or olanzapine pamoate (0 and 6%). Results of the database research indicate that a higher percentage of patients treated with paliperidone palmitate continued therapy and restarted therapy than patients receiving the other three long-acting antipsychotics. Co-medication against extrapyramidal symptoms was more frequently used with haloperidol decanoate. FINANCIAL SUPPORT: This work was funded by Janssen." @default.
- W2170917127 created "2016-06-24" @default.
- W2170917127 creator A5001233968 @default.
- W2170917127 creator A5017069242 @default.
- W2170917127 creator A5019209944 @default.
- W2170917127 creator A5020117752 @default.
- W2170917127 creator A5037782521 @default.
- W2170917127 creator A5071597889 @default.
- W2170917127 creator A5081939900 @default.
- W2170917127 date "2015-11-01" @default.
- W2170917127 modified "2023-09-26" @default.
- W2170917127 title "Treatment Continuation And Treatment Characteristics Of Four Long Acting Antipsychotic Medications (Paliperidone Palmitate, Risperidone Microspheres, Olanzapine Pamoate And Haloperidol Decanoate) In The Netherlands" @default.
- W2170917127 doi "https://doi.org/10.1016/j.jval.2015.09.960" @default.
- W2170917127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26532297" @default.
- W2170917127 hasPublicationYear "2015" @default.
- W2170917127 type Work @default.
- W2170917127 sameAs 2170917127 @default.
- W2170917127 citedByCount "2" @default.
- W2170917127 countsByYear W21709171272017 @default.
- W2170917127 countsByYear W21709171272021 @default.
- W2170917127 crossrefType "journal-article" @default.
- W2170917127 hasAuthorship W2170917127A5001233968 @default.
- W2170917127 hasAuthorship W2170917127A5017069242 @default.
- W2170917127 hasAuthorship W2170917127A5019209944 @default.
- W2170917127 hasAuthorship W2170917127A5020117752 @default.
- W2170917127 hasAuthorship W2170917127A5037782521 @default.
- W2170917127 hasAuthorship W2170917127A5071597889 @default.
- W2170917127 hasAuthorship W2170917127A5081939900 @default.
- W2170917127 hasBestOaLocation W21709171271 @default.
- W2170917127 hasConcept C118552586 @default.
- W2170917127 hasConcept C126322002 @default.
- W2170917127 hasConcept C2776412080 @default.
- W2170917127 hasConcept C2776619155 @default.
- W2170917127 hasConcept C2776921671 @default.
- W2170917127 hasConcept C2777126507 @default.
- W2170917127 hasConcept C2780057945 @default.
- W2170917127 hasConcept C2780494398 @default.
- W2170917127 hasConcept C2780616385 @default.
- W2170917127 hasConcept C2780948584 @default.
- W2170917127 hasConcept C2908997079 @default.
- W2170917127 hasConcept C42219234 @default.
- W2170917127 hasConcept C513476851 @default.
- W2170917127 hasConcept C71924100 @default.
- W2170917127 hasConcept C98274493 @default.
- W2170917127 hasConceptScore W2170917127C118552586 @default.
- W2170917127 hasConceptScore W2170917127C126322002 @default.
- W2170917127 hasConceptScore W2170917127C2776412080 @default.
- W2170917127 hasConceptScore W2170917127C2776619155 @default.
- W2170917127 hasConceptScore W2170917127C2776921671 @default.
- W2170917127 hasConceptScore W2170917127C2777126507 @default.
- W2170917127 hasConceptScore W2170917127C2780057945 @default.
- W2170917127 hasConceptScore W2170917127C2780494398 @default.
- W2170917127 hasConceptScore W2170917127C2780616385 @default.
- W2170917127 hasConceptScore W2170917127C2780948584 @default.
- W2170917127 hasConceptScore W2170917127C2908997079 @default.
- W2170917127 hasConceptScore W2170917127C42219234 @default.
- W2170917127 hasConceptScore W2170917127C513476851 @default.
- W2170917127 hasConceptScore W2170917127C71924100 @default.
- W2170917127 hasConceptScore W2170917127C98274493 @default.
- W2170917127 hasIssue "7" @default.
- W2170917127 hasLocation W21709171271 @default.
- W2170917127 hasOpenAccess W2170917127 @default.
- W2170917127 hasPrimaryLocation W21709171271 @default.
- W2170917127 hasRelatedWork W2002564282 @default.
- W2170917127 hasRelatedWork W2040013231 @default.
- W2170917127 hasRelatedWork W2102101987 @default.
- W2170917127 hasRelatedWork W2122894574 @default.
- W2170917127 hasRelatedWork W2168030456 @default.
- W2170917127 hasRelatedWork W2170917127 @default.
- W2170917127 hasRelatedWork W2289786440 @default.
- W2170917127 hasRelatedWork W3082150948 @default.
- W2170917127 hasRelatedWork W3120303634 @default.
- W2170917127 hasRelatedWork W2184537739 @default.
- W2170917127 hasVolume "18" @default.
- W2170917127 isParatext "false" @default.
- W2170917127 isRetracted "false" @default.
- W2170917127 magId "2170917127" @default.
- W2170917127 workType "article" @default.